A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
暂无分享,去创建一个
H. Ikematsu | Yutaka Saito | Y. Morine | M. Shimada | T. Ikemoto | Ken Kato | A. Goel | F. Balaguer | L. Bujanda | H. Takamaru | M. Pellisé | T. Murano | Yu Saito | Yuma Wada | Y. Wada | A. Goel
[1] J. Tuynman,et al. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study , 2020, Modern Pathology.
[2] E. Dekker,et al. Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme , 2019, Gut.
[3] T. Sugino,et al. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer. , 2019, American journal of clinical pathology.
[4] P. Saliou,et al. Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer , 2019, Scientific Reports.
[5] F. Gao,et al. Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-Risk T1 Colorectal Cancers. , 2019, Gastroenterology.
[6] T. Churchill,et al. Analysis of postdischarge costs following emergent general surgery in elderly patients. , 2018, Canadian journal of surgery. Journal canadien de chirurgie.
[7] J. Fleshman,et al. A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes. , 2017, Gastroenterology.
[8] Min Jung Kim,et al. Histopathologic risk factors for lymph node metastasis in patients with T1 colorectal cancer , 2017, Annals of surgical treatment and research.
[9] K. Chayama,et al. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group , 2017, Journal of Gastroenterology.
[10] P. Siersema,et al. Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes , 2016, Gut.
[11] Y. Toiyama,et al. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Eun Hye Kim,et al. The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer , 2016, Medicine.
[13] M. Fujishiro,et al. Outcome of salvage surgery for colorectal cancer initially treated by upfront endoscopic therapy. , 2016, Surgery.
[14] R. Warschkow,et al. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis , 2016, Surgical Endoscopy.
[15] I. Christensen,et al. Intra-tumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer. , 2016, Experimental and molecular pathology.
[16] Y. Toiyama,et al. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer , 2015, Gut.
[17] M. Rugge,et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2015, Endoscopy.
[18] Masahiro Yoshida,et al. JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection , 2015, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[19] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer , 2011, International Journal of Clinical Oncology.
[20] Y. Toiyama,et al. Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer , 2014, Annals of surgery.
[21] T. Joh,et al. Magnifying chromoendoscopy and endoscopic ultrasonography measure invasion depth of early stage colorectal cancer with equal accuracy on the basis of a prospective trial. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] K. Kaneko,et al. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer , 2013, Endoscopy.
[23] Y. Toiyama,et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.
[24] K. Kaneko,et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. , 2013, Gastroenterology.
[25] S. Rai,et al. Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer , 2012, Annals of surgery.
[26] K. Chayama,et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection , 2012, Journal of gastroenterology and hepatology.
[27] M. Kim,et al. Predictors for lymph node metastasis in T1 colorectal cancer , 2012, Endoscopy.
[28] M. Mukai,et al. Risk Factors for Postoperative Recurrence in Patients with Pathologically T1 Colorectal Cancer , 2012, World Journal of Surgery.
[29] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[30] Tadakazu Shimoda,et al. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma , 2010, Modern Pathology.
[31] Seung-Yong Jeong,et al. Indications for Subsequent Surgery After Endoscopic Resection of Submucosally Invasive Colorectal Carcinomas: A Prospective Cohort Study , 2009, Diseases of the colon and rectum.
[32] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[33] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[34] S. H. Park,et al. Characteristics of early colorectal carcinoma with lymph node metastatic disease. , 2008, Hepato-gastroenterology.
[35] M. Stamos,et al. Management of Early Rectal T1 and T2 Cancers , 2007, Clinical Cancer Research.
[36] D. Rothenberger,et al. Population-based analyses of lymph node metastases in colorectal cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[37] Dong Hyun Choi,et al. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type , 2006, Journal of Clinical Pathology.
[38] David M Studdert,et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. , 2005, JAMA.
[39] J. Guillem,et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum , 2004, Journal of Gastrointestinal Surgery.
[40] Hidetaka Mochizuki,et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.
[41] H. Baba,et al. The risk of lymph node metastasis in T1 colorectal carcinoma. , 2004, Hepato-gastroenterology.
[42] L. Burgart,et al. Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.
[43] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[44] K. Haruma,et al. Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion. , 2000, Oncology reports.